Your browser doesn't support javascript.
loading
Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study.
Cheng, Ann-Lii; Kang, Yoon-Koo; He, Aiwu Ruth; Lim, Ho Yeong; Ryoo, Baek-Yeol; Hung, Chao-Hung; Sheen, I-Shyan; Izumi, Namiki; Austin, TaShara; Wang, Qiang; Greenberg, Jonathan; Shiratori, Shinichi; Beckman, Robert A; Kudo, Masatoshi.
Afiliación
  • Cheng AL; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: alcheng@ntu.edu.tw.
  • Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • He AR; Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  • Lim HY; Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea.
  • Ryoo BY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Hung CH; Chang Gung Medical Foundation-Kaohsiung, Kaohsiung, Taiwan.
  • Sheen IS; Chang Gung Medical Foundation-Linkuo, Taoyaun, Taiwan.
  • Izumi N; Japan Red Cross Musashino Hospital, Tokyo, Japan.
  • Austin T; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Wang Q; Daiichi Sankyo Pharma Development, Edison, NJ, USA.
  • Greenberg J; Daiichi Sankyo Pharma Development, Edison, NJ, USA.
  • Shiratori S; Daiichi Sankyo Pharma Development, Edison, NJ, USA.
  • Beckman RA; Department of Oncology, Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA; Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center and Innovation Center for Bi
  • Kudo M; Kinki University Hospital, Osaka, Japan.
J Hepatol ; 63(4): 896-904, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26071796
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Niacinamida / Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Neoplasias Hepáticas / Estadificación de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2015 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Niacinamida / Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Neoplasias Hepáticas / Estadificación de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2015 Tipo del documento: Article Pais de publicación: Países Bajos